In an unintended consequence of the new health care law, drug companies have begun notifying children’s hospitals around the country that they no longer qualify for large discounts on drugs used to treat rare medical conditions.
As a result, prices are going up for these specialized “orphan drugs,” some of which are also used to treat more common conditions.
Over the last 18 years, Congress has required drug manufacturers to provide discounts to a variety of health care providers, including community health centers, AIDS CLINCIS and hospitals that care for large numbers of low-income people.
Several years ago, Congress broadened the program to include children’s hospitals. But this year Congress, in revising the drug discount program as part of the new health care law, blocked these hospitals from continuing to receive price cuts on orphan drugs intended for treatment of diseases affecting fewer than 200,000 people in the United States.
Answer by Anonymous at 11:04 AM on Dec. 9, 2010
Answer by Carpy at 11:06 AM on Dec. 9, 2010
Answer by itsmesteph11 at 11:09 AM on Dec. 9, 2010
Answer by jewjewbee at 11:12 AM on Dec. 9, 2010
Answer by brandyj at 11:20 AM on Dec. 9, 2010
Answer by Anonymous at 11:28 AM on Dec. 9, 2010
Answer by tootoobusy at 11:33 AM on Dec. 9, 2010
Answer by lovinangels at 11:35 AM on Dec. 9, 2010
Answer by Mom2Just1 at 11:39 AM on Dec. 9, 2010
Answer by TARARENEE at 11:49 AM on Dec. 9, 2010
Check out some of the top posts today in Groups: